Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mouwasat Medical Services CoSAU:4002 +0.25%100 PB Ratio is 3.06 as of Jul. 18, 2026, which is 47% below its 10-year median of 5.77. GuruFocus rates SAU:4002 with a GF Score™ of 100/100 and a GF Value™ of ﷼109.50 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 610 Healthcare Providers & Services companies, Mouwasat Medical Services Co ranks worse than 67.87% on this metric.
Mouwasat Medical Services Co stock PB Ratio (=3.12) is close to 10-year low of 3.12.
The historical rank and industry rank for Mouwasat Medical Services Co's PB Ratio or its related term are showing as below:
SAU:4002'
s PB Ratio Range Over the Past 10 Years
Min: 3.05 Med: 5.77 Max: 9.71
Current: 3.06
During the past 13 years, Mouwasat Medical Services Co's highest PB Ratio was 9.71. The lowest was 3.05. And the median was 5.77.
SAU:4002's PB Ratio is ranked worse than 67.87% of 610
companies
in the Healthcare Providers & Services industry
Industry Median: 2.025
vs SAU:4002: 3.06
During the past 12 months, Mouwasat Medical Services Co's average Book Value Per Share Growth Rate was 5.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 8.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 10.80% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 13.50% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Mouwasat Medical Services Co was 18.60% per year. The lowest was 8.90% per year. And the median was 14.00% per year.
Back to Basics: PB Ratio
Mouwasat Medical Services Co (SAU:4002) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Mouwasat Medical Services Co PB Ratio Related Terms
Mouwasat Medical Services Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Mouwasat Medical Services Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mouwasat Medical Services Co PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mouwasat Medical Services Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Mouwasat Medical Services Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Mouwasat Medical Services Co (SAU:4002) has a PB Ratio of 3.06 as of Jul. 18, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Mouwasat Medical Services Co and its competitors. This is 47% below median its historical median of 5.77. Over the past decade, Mouwasat Medical Services Co's PB Ratio has ranged from 3.05 to 9.71. According to the industry distribution chart, Mouwasat Medical Services Co ranks #414 out of 610 companies in the Healthcare Providers & Services industry, placing it in the top 67.9%.
Is Mouwasat Medical Services Co's PB Ratio too high?
Mouwasat Medical Services Co's current PB Ratio of 3.06 is 47% below median its 10-year median of 5.77. Over the past 10 years, this metric has ranged from a low of 3.05 to a high of 9.71. The Healthcare Providers & Services industry median PB Ratio is 2.03. Mouwasat Medical Services Co's value of 3.06 is 51.1% above this industry median. Based on the distribution chart, Mouwasat Medical Services Co ranks #414 out of 610 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Mouwasat Medical Services Co has a GF Score™ of 100/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mouwasat Medical Services Co's PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Mouwasat Medical Services Co ranks #414 out of 610 companies for PB Ratio. This places Mouwasat Medical Services Co in the lower half of its industry. The industry median PB Ratio is 2.03. Mouwasat Medical Services Co's value of 3.06 is 51.1% above this benchmark. Historically, Mouwasat Medical Services Co's own PB Ratio has ranged from 3.05 to 9.71 over the past decade. While the company's 10-year median is 5.77 vs. the industry median of 2.03, Mouwasat Medical Services Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.03, based on 610 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mouwasat Medical Services Co's current PB Ratio of 3.06 is 51.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Mouwasat Medical Services Co and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mouwasat Medical Services Co's current PB Ratio is 3.06, which is 47% below median its own 10-year median of 5.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mouwasat Medical Services Co stock overvalued right now?
Based on GuruFocus' analysis, Mouwasat Medical Services Co (SAU:4002) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼109.50, compared to a current price of ﷼60.90 — trading 44.4% below its estimated fair value. The current PB Ratio is 3.06, which is 47% below median its 10-year median of 5.77 and 51.1% above the Healthcare Providers & Services industry median of 2.03. Mouwasat Medical Services Co's overall GF Score™ is 100/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Mouwasat Medical Services Co (SAU:4002), the current PB Ratio is 3.06 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mouwasat Medical Services Co (SAU:4002) Overvalued in 2026?
Based on GuruFocus' analysis, Mouwasat Medical Services Co stock appears to be undervalued.
The current stock price of ﷼60.90 is trading 44.4% below its estimated GF Value™ of ﷼109.50.
GuruFocus considers Mouwasat Medical Services Co to be Significantly Undervalued.
Key valuation signals for SAU:4002:
PB Ratio: 3.06 (47% below median its 10-year median of 5.77)
GF Value™: ﷼109.50 vs. price of ﷼60.90 (44.4% below fair value)
Industry Position: 51.1% above the Healthcare Providers & Services median (#414 of 610)
No single metric tells the full story. See the SAU:4002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mouwasat Medical Services Co is engaged in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, pharmacies, and wholesale of medical equipment and drugs. The company also operates skin care centers that offer clinical and cosmetic dermatology, aesthetic and reconstructive plastic surgery, weight reduction, and esthetician services. It operates in two segments Medical Services segment and Pharmaceuticals out of which the Medical Services segment derives the majority of revenue. The Medical Services segment includes Inpatient and outpatient services. The company provides specialized centers: Eye Center, Robotic Surgeries Center, Diabetes Center, Fertility Unit, Cardiology Center, Stroke Unit, Long Term Care Center, Obesity Center, and others.
100GF Score
Get the complete analysis for SAU:4002
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4002 has been successfully added to your 
